CAS: 1257358-38-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Gontivimab REF: TM-T77027CAS: 1257358-38-5 | ≥95% (SDS-PAGE/SEC-HPLC) - ≥95% (SDS-PAGE/SEC-HPLC) | 204.00 €~1,522.00 € | Tue 21 Jan 25 |
 | Gontivimab REF: 3D-CLA1411CAS: 1257358-38-5 | - - - | To inquire | Tue 28 Jan 25 |
Gontivimab
CAS:1257358-38-5
Gontivimab (ALX-0171) is a trivalent nanobody targeting hRSV fusion (F) protein with anti-RSV antiviral properties.
Purity:
≥95% (SDS-PAGE/SEC-HPLC) - ≥95% (SDS-PAGE/SEC-HPLC)
Color and Shape:
Liquid
Ref: TM-T77027
| 1mg | 204.00 € | ||
| 5mg | 494.00 € | ||
| 10mg | 707.00 € | ||
| 25mg | 1,103.00 € | ||
| 50mg | 1,522.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Ref: 3D-CLA1411
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 28 Jan 2025
